Evidence map›Paper›PMID 37248990›Full record

ArticleThe European journal of general practice2023

The experiences of patients ill with COVID-19-like symptoms and the role of testing for SARS-CoV-2 in supporting them: A qualitative study in eight European countries during the first wave of the pandemic.

Melanie E Hoste, Marta Wanat, Nina Gobat, Marilena Anastasaki, Femke Böhmer, Sławomir Chlabicz, Annelies Colliers, Karen Farrell, Maria-Nefeli Karkana, John Kinsman and 11 more

Open access · goldAbstract read
In one paragraph

Article in The European journal of general practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 8 countries.

Melanie E HosteDepartment of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.ORCID 0000-0003-0831-3354
Marta WanatNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Nina GobatNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Marilena AnastasakiFaculty of Medicine, Clinic of Social and Family Medicine, University of Crete, Crete, Greece.
Femke BöhmerInstitute of General Practice, Rostock University Medical Center, Rostock, Germany.
Sławomir ChlabiczDepartment of Family Medicine, Medical University of Białystok, Białystok, Poland.
Annelies ColliersDepartment of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.ORCID 0000-0003-4960-2355
Karen FarrellSchool of Medicine, National University of Ireland, Galway, Ireland.
Maria-Nefeli KarkanaEuropean Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
John KinsmanEuropean Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
Christos LionisFaculty of Medicine, Clinic of Social and Family Medicine, University of Crete, Crete, Greece.ORCID 0000-0002-9324-2839
Ludmila MarcinowiczDepartment of Obstetrics, Gynaecology and Maternity Care, Medical University of Białystok, Białystok, Poland.
Katrin ReinhardtInstitute of General Practice, Rostock University Medical Center, Rostock, Germany.
Ingmarie SkoglundGeneral Practice/Family Medicine, Primary Health Care, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Pär-Daniel SundvallGeneral Practice/Family Medicine, Primary Health Care, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Akke VellingaSchool of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.ORCID 0000-0002-6583-4300
Herman GoossensLaboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Christopher C ButlerNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Alike van der VeldenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Sarah Tonkin-CrineNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Sibyl AnthierensDepartment of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.
University of Antwerp · BEEuropean Centre for Disease Prevention and Control · SEMedical University of Białystok · PLPublic Health England · GBRegion Västra Götaland · SEUniversity of Crete · GRUniversity of Oxford · GBUniversity of Rostock · DEOllscoil na Gaillimhe – University of Galway · IEUniversity College Dublin · IEUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccess to testing during the first wave of the COVID-19 pandemic was limited, impacting patients with COVID-19-like symptoms. Current qualitative studies have been limited to one country or were conducted outside Europe.

objectivesTo explore - in eight European countries - the experiences of patients consulting in primary care with COVID-19-like symptoms during the first wave of the pandemic.

methodsSixty-six semi-structured interviews, informed by a topic guide, were conducted by telephone or in person between April and July 2020. Patients with COVID-19-like symptoms were purposively recruited in primary care sites in eight countries and sampled based on age, gender, and symptom presentation. Deductive and inductive thematic analysis techniques were used to develop a framework representing data across settings. Data adequacy was attained by collecting rich data.

resultsSeven themes were identified, which described the experiences of patients consulting. Two themes are reported in this manuscript describing the role of COVID-19 testing in this experience. Patients described significant distress due to their symptoms, especially those at higher risk of complications from COVID-19, and those with severe symptoms. Patients wanted access to testing to identify the cause of their illness and minimise the burden of managing uncertainty. Some patients testing positive for COVID-19 assumed they would be immune from future infection.

conclusionPatients experiencing novel and severe symptoms, particularly those with comorbidities, experienced a significant emotional and psychological burden due to concerns about COVID-19. Testing provided reassurance over health status and helped patients identify which guidance to follow. Testing positive for SARS-CoV-2 led to some patients thinking they were immune from future infection, thus influencing subsequent behaviour.

Indexed as

COVID-19COVID-19 TestingEmotionsHumansPandemicsSARS-CoV-2patientsprimary careQualitative researchSARS-CoV-2testing

Identifiers

PMID37248990
PMCPMC10249444
OpenAlexW4378745016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.